Robert Hayman 0:04
Robert, so my name is Robert Hayman. I ran a company called discus Dental. We started, and after about 15 years, we were number one direct manufacturing company in the industry. We had a tremendous success. We were creative. We had amazing culture, great leadership, and it was really a lot of fun. Humor was a big part of our culture. This right here, we were a whitening juggernaut more than anything else, but this one product here was representative of probably over 50% of whitening revenues in the entire industry globally. This is called Zoom light activated chair side tooth whitening. Really a fantastic product. This is bright smile. We essentially acquired bright smile after we put them out of business, got their assets, got their patents and everything else. So that was interesting. And I worked on Invisalign as well. When align technologies launched, they launched the orthos asked us for help with the GPS. We helped them out a great deal, and we really knocked the cover off the ball strategically, completely different. And the way that we handle everything is very different from orthos. But it was really a lot of fun. I'm happy to have it very, very deep bench of experience here. These guys have all done it before. They all have experience in the dental industry. Some have a lot of experience in the dental industry, but all of them are very, very capable. I'm very blessed to have a terrific team. So why we're here today? It's the interview system, and interview is is a very big statement here. This will become the number one diagnostic in our industry, and I'll explain why. It's an audacious statement, but I'll explain why, and I think you'll actually agree with me when it's done, it'll be used by every dentist, every specialty in most procedures, it is quick, it's noninvasive. There's no pain and there's no radiation. When I say quick, it's two seconds per tooth, and literally 60 seconds for the entire oral cavity. This will become a new standard of care very quickly. So what does it do? Exactly? Well, it identifies or detects damage. And by damage, what we mean are cracks and failing restorations. And by restorations, we're talking about crowns, veneers, fillings, or a lot of people call cavities, inlays and onlays, and those are all the restorations. So what about X rays? People ask about, well, don't they detect cracks. Well, here's a tooth. It's an endodonically treated tooth. It's a molar, and it's an x ray. Well, look what the X Ray did not pick up, and that's because x radiographs primarily detect decay and some bone related issues, but not damage, which is again, cracks and failing restorations and damage is a far bigger problem. This is why the statement, the audacious statement, this will become the number one diagnostic, which is now radiographs, because damage is three to four times more common, more prevalent than decay or bone related issues. So 80% of patients are leaving their dental exams with some form of tooth damage. And you know, these are oftentimes cracks, and they usually start out small, but they never really heal without some form of intervention. Think about your windshield. Who hasn't gotten a small crack on your windshield, but it goes all the way across, and sooner or later, you have to replace the windshield. Nothing today exists that accurately and consistently detects it. This is easily dentistry is number one unmet diagnostic need. So today's number one diagnostic for damage, pain, and that's not funny. Dentists hate this. These are valuable procedures walking out of the door. Many are urgent, and some are going to become catastrophic by catastrophic guts and extraction. Dentists are essentially today, in this regards, flying blind. So for the first time ever, clinicians, and this is dentists and hygienists, are going to get assessment percentage probabilities on failing restorations, all four of the different crack types we can identify now damaged Pdl, specifically a damaged Pdl, which is huge, and all three of the different mobility types. What we do is predictive analysis, and yes, we can identify static snapshot on time patient comes in, this tooth is hurting, and we can tell them what's wrong. Often, a lot of times, it's not the tooth they're pointing at, it's the adjacent dentition and the opposing dentition. Within two seconds per tooth, we can interview each tooth and how many of you have heard let's just watch that, because they don't know what's wrong with it. They can't tell you if it's a crack. More important is the dynamic health, health history, trend line. This happens mostly in the hygiene room. They get the first reading right here. It's a 20. It's low. And they after at every hygiene appointment, it goes up if it's if there's a problem, and this becomes gets to a point where it could become catastrophic, and at some point you want to have some intervention. So for the first time ever, a clinician and a patient are going to determine when is the appropriate time to intervene and what to do about it. So 90% of. GPS. This was a market research study that we did, validation study when we started the project, 90% of GPS would use the technology. Believe that integrating interview into their practices, into their exams, would generate significant revenue. That's important. 100% of GPS and hygienists would use the technology if it took three minutes or less. We're down to 60 seconds now, and I think it'll get even quicker. 78% almost 80% would use would purchase the system if the handpiece was under $1,500 we're there. So how does it work? It's called percussion, quantitative percussion diagnostics, or QPD for short. It's like tapping a glass. Glass has it's it's healthy. Has a water in. It sounds one way. It has a crack in. It sounds completely different. We pick up those. We pick up those, those. That energy wave, and it goes up into the cloud, into our algorithms, comes back almost real time on the screen, into the the image that I just showed you for the UI. So how big is the market? 400,000 dentists and hygienists in the United States alone. It's split fairly evenly between the two, and there's 800 million plus procedures in just the US. That's a $5.6 billion total addressable market. That's massive in our industry. Globally, it's 14 billion plus in total addressable market revenue, artificial intelligence. We have the largest data collection in in the world, 1 million and counting. We use finite element analysis modeling to train the algorithms. It's a supercomputer, and also replicate teeth. This is a sinusoidal wave we now can use and read various aspects of the of the tooth, the different parts of the wave, and we're beginning to be able to distinguish different types of cracks. So we can detect PDL health diagnostics with percentiles. And now we're going to be distinguishing versus just detecting cracks. So the revenue model, we're razor razor blade SaaS model, our razor and our razor blade are all profitable, 80% gross margin on that. And of course, the SAS is 100% intellectual property. We have, we have 21 patents, all global and some pending. We received one second FDA, 510, K approval in September. That was for the system and mobility. We've applied for the second one. We're hoping to have approval any time now. Could be any day, 28 clinical studies, most of these peer reviewed and also published in the most prestigious journal in our industry, which is JPD. Many of them on the front cover. I already spoke to the 21 patents. So financially speaking, this is very hard for you to see. We grow from a revenue of, you know, first year 13 million, and year number four, number five, it goes down to 100 and what is that? 337 million. And so we feel this is very conservative. It's not a huge market share. It's less than 5% globally. And so we have a lot more my history, having developed and launched 35 successful brands, all different types, whether it's products, whether it's technologies, whether it's medical technologies, devices, we beat the hell out of this. Quite frankly, this is a revenue by product. It's just an interesting chart. That's total revenue in green, that's the hand, that's the disposable tip, and that's the SaaS fees. And then you can see there's a convergence here between the tip and the and the SaaS fee over a period of time. Fundraising update, we're raising 10 million some point in q2 and we've already got some of it. We got a lot of commitments coming in, and it's really to fund the launch. That's my contact info. So you got five seconds to ask questions. Now, if you have any questions, just take a picture of this, and I'm happy to answer the questions for you.
Robert Hayman 0:04
Robert, so my name is Robert Hayman. I ran a company called discus Dental. We started, and after about 15 years, we were number one direct manufacturing company in the industry. We had a tremendous success. We were creative. We had amazing culture, great leadership, and it was really a lot of fun. Humor was a big part of our culture. This right here, we were a whitening juggernaut more than anything else, but this one product here was representative of probably over 50% of whitening revenues in the entire industry globally. This is called Zoom light activated chair side tooth whitening. Really a fantastic product. This is bright smile. We essentially acquired bright smile after we put them out of business, got their assets, got their patents and everything else. So that was interesting. And I worked on Invisalign as well. When align technologies launched, they launched the orthos asked us for help with the GPS. We helped them out a great deal, and we really knocked the cover off the ball strategically, completely different. And the way that we handle everything is very different from orthos. But it was really a lot of fun. I'm happy to have it very, very deep bench of experience here. These guys have all done it before. They all have experience in the dental industry. Some have a lot of experience in the dental industry, but all of them are very, very capable. I'm very blessed to have a terrific team. So why we're here today? It's the interview system, and interview is is a very big statement here. This will become the number one diagnostic in our industry, and I'll explain why. It's an audacious statement, but I'll explain why, and I think you'll actually agree with me when it's done, it'll be used by every dentist, every specialty in most procedures, it is quick, it's noninvasive. There's no pain and there's no radiation. When I say quick, it's two seconds per tooth, and literally 60 seconds for the entire oral cavity. This will become a new standard of care very quickly. So what does it do? Exactly? Well, it identifies or detects damage. And by damage, what we mean are cracks and failing restorations. And by restorations, we're talking about crowns, veneers, fillings, or a lot of people call cavities, inlays and onlays, and those are all the restorations. So what about X rays? People ask about, well, don't they detect cracks. Well, here's a tooth. It's an endodonically treated tooth. It's a molar, and it's an x ray. Well, look what the X Ray did not pick up, and that's because x radiographs primarily detect decay and some bone related issues, but not damage, which is again, cracks and failing restorations and damage is a far bigger problem. This is why the statement, the audacious statement, this will become the number one diagnostic, which is now radiographs, because damage is three to four times more common, more prevalent than decay or bone related issues. So 80% of patients are leaving their dental exams with some form of tooth damage. And you know, these are oftentimes cracks, and they usually start out small, but they never really heal without some form of intervention. Think about your windshield. Who hasn't gotten a small crack on your windshield, but it goes all the way across, and sooner or later, you have to replace the windshield. Nothing today exists that accurately and consistently detects it. This is easily dentistry is number one unmet diagnostic need. So today's number one diagnostic for damage, pain, and that's not funny. Dentists hate this. These are valuable procedures walking out of the door. Many are urgent, and some are going to become catastrophic by catastrophic guts and extraction. Dentists are essentially today, in this regards, flying blind. So for the first time ever, clinicians, and this is dentists and hygienists, are going to get assessment percentage probabilities on failing restorations, all four of the different crack types we can identify now damaged Pdl, specifically a damaged Pdl, which is huge, and all three of the different mobility types. What we do is predictive analysis, and yes, we can identify static snapshot on time patient comes in, this tooth is hurting, and we can tell them what's wrong. Often, a lot of times, it's not the tooth they're pointing at, it's the adjacent dentition and the opposing dentition. Within two seconds per tooth, we can interview each tooth and how many of you have heard let's just watch that, because they don't know what's wrong with it. They can't tell you if it's a crack. More important is the dynamic health, health history, trend line. This happens mostly in the hygiene room. They get the first reading right here. It's a 20. It's low. And they after at every hygiene appointment, it goes up if it's if there's a problem, and this becomes gets to a point where it could become catastrophic, and at some point you want to have some intervention. So for the first time ever, a clinician and a patient are going to determine when is the appropriate time to intervene and what to do about it. So 90% of. GPS. This was a market research study that we did, validation study when we started the project, 90% of GPS would use the technology. Believe that integrating interview into their practices, into their exams, would generate significant revenue. That's important. 100% of GPS and hygienists would use the technology if it took three minutes or less. We're down to 60 seconds now, and I think it'll get even quicker. 78% almost 80% would use would purchase the system if the handpiece was under $1,500 we're there. So how does it work? It's called percussion, quantitative percussion diagnostics, or QPD for short. It's like tapping a glass. Glass has it's it's healthy. Has a water in. It sounds one way. It has a crack in. It sounds completely different. We pick up those. We pick up those, those. That energy wave, and it goes up into the cloud, into our algorithms, comes back almost real time on the screen, into the the image that I just showed you for the UI. So how big is the market? 400,000 dentists and hygienists in the United States alone. It's split fairly evenly between the two, and there's 800 million plus procedures in just the US. That's a $5.6 billion total addressable market. That's massive in our industry. Globally, it's 14 billion plus in total addressable market revenue, artificial intelligence. We have the largest data collection in in the world, 1 million and counting. We use finite element analysis modeling to train the algorithms. It's a supercomputer, and also replicate teeth. This is a sinusoidal wave we now can use and read various aspects of the of the tooth, the different parts of the wave, and we're beginning to be able to distinguish different types of cracks. So we can detect PDL health diagnostics with percentiles. And now we're going to be distinguishing versus just detecting cracks. So the revenue model, we're razor razor blade SaaS model, our razor and our razor blade are all profitable, 80% gross margin on that. And of course, the SAS is 100% intellectual property. We have, we have 21 patents, all global and some pending. We received one second FDA, 510, K approval in September. That was for the system and mobility. We've applied for the second one. We're hoping to have approval any time now. Could be any day, 28 clinical studies, most of these peer reviewed and also published in the most prestigious journal in our industry, which is JPD. Many of them on the front cover. I already spoke to the 21 patents. So financially speaking, this is very hard for you to see. We grow from a revenue of, you know, first year 13 million, and year number four, number five, it goes down to 100 and what is that? 337 million. And so we feel this is very conservative. It's not a huge market share. It's less than 5% globally. And so we have a lot more my history, having developed and launched 35 successful brands, all different types, whether it's products, whether it's technologies, whether it's medical technologies, devices, we beat the hell out of this. Quite frankly, this is a revenue by product. It's just an interesting chart. That's total revenue in green, that's the hand, that's the disposable tip, and that's the SaaS fees. And then you can see there's a convergence here between the tip and the and the SaaS fee over a period of time. Fundraising update, we're raising 10 million some point in q2 and we've already got some of it. We got a lot of commitments coming in, and it's really to fund the launch. That's my contact info. So you got five seconds to ask questions. Now, if you have any questions, just take a picture of this, and I'm happy to answer the questions for you.
Market Intelligence
Schedule an exploratory call
Request Info17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647
714-847-3540© 2024 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy